TY  - GEN
AU  - Yutani,Shigeru
AU  - Shirahama,Takahisa
AU  - Muroya,Daisuke
AU  - Matsueda,Satoko
AU  - Yamaguchi,Rin
AU  - Morita,Michi
AU  - Shichijo,Shigeki
AU  - Yamada,Akira
AU  - Sasada,Tetsuro
AU  - Itoh,Kyogo
TI  - Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
SN  - 1349-7006
PY  - 2017///1016
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Cancer Vaccines
KW  - Carcinoma, Hepatocellular
KW  - mortality
KW  - Chemoembolization, Therapeutic
KW  - Combined Modality Therapy
KW  - Drug Resistance, Neoplasm
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Precision Medicine
KW  - Sorafenib
KW  - T-Lymphocytes, Cytotoxic
KW  - physiology
KW  - Treatment Outcome
KW  - Vaccination
KW  - Vaccines, Subunit
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1111/cas.13301
ER  -